Requires health insurance coverage for early-stage kidney disease screening without cost sharing.
Introduced First Reading Senate Referred to SCM
Email me when S 4243 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 4243. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill mandates that all health‑insurance contracts and plans in New Jersey pay for a physician‑ordered early‑stage kidney disease test—either an eGFR blood test or a urine albumin‑creatinine ratio—without any deductible, copayment, or other cost‑sharing. It applies to individual, group, hospital‑service, health‑service, and state‑run benefit contracts, as well as high‑deductible and catastrophic plans, provided the test is deemed medically necessary. The goal is to catch chronic kidney disease earlier, as hospital admissions for the condition have risen sharply in the state.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 4243
3 free questions a day, no accountHistory
- Introduced in the Senate, Referred to Senate Commerce Committee
Sponsors
- Wimberly, Benjie E. (D) · sponsor
- McKnight, Angela V.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 4243 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 4243 freeOr ask your AI assistant about S 4243 directly:
Add to Claude, ChatGPT or Cursor